Ignite Creation Date:
2025-12-25 @ 12:06 AM
Ignite Modification Date:
2026-01-01 @ 2:22 PM
Study NCT ID:
NCT02609958
Status:
COMPLETED
Last Update Posted:
2018-05-29
First Post:
2015-11-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy
Sponsor:
ASLAN Pharmaceuticals